bibliographic resource 3733976 [br/3733976]
https://w3id.org/oc/corpus/br/3733976

is a

• document
• article

title

• A Multicenter, Open-Label Phase II Clinical Trial of Combined MEK plus EGFR Inhibition for Chemotherapy-Refractory Advanced Pancreatic Adenocarcinoma

publication date

• 2015-01-01

contributor

• https://w3id.org/oc/corpus/ar/14146572
• https://w3id.org/oc/corpus/ar/14146573
• https://w3id.org/oc/corpus/ar/14146574
• https://w3id.org/oc/corpus/ar/14146575
• https://w3id.org/oc/corpus/ar/14146576
• https://w3id.org/oc/corpus/ar/14146577
• https://w3id.org/oc/corpus/ar/14146578
• https://w3id.org/oc/corpus/ar/14146579
• https://w3id.org/oc/corpus/ar/14146580
• https://w3id.org/oc/corpus/ar/14146581
• https://w3id.org/oc/corpus/ar/14146582
• https://w3id.org/oc/corpus/ar/14146583
• https://w3id.org/oc/corpus/ar/14146584
• https://w3id.org/oc/corpus/ar/14146585
• https://w3id.org/oc/corpus/ar/14146586
• https://w3id.org/oc/corpus/ar/14146587
• https://w3id.org/oc/corpus/ar/14146588
• https://w3id.org/oc/corpus/ar/14146589
• https://w3id.org/oc/corpus/ar/14146590

format

• https://w3id.org/oc/corpus/re/2074684

identifier

• https://w3id.org/oc/corpus/id/7368014
• https://w3id.org/oc/corpus/id/7368015
• https://w3id.org/oc/corpus/id/7368016
• https://w3id.org/oc/corpus/id/7368017

part of

• https://w3id.org/oc/corpus/br/463971